Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 167.50 165.00 170.00 167.50 167.50 167.50 32,976 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 49.2 -56.5 -72.8 - 300

Amryt Pharma Share Discussion Threads

Showing 4676 to 4690 of 6675 messages
Chat Pages: Latest  195  194  193  192  191  190  189  188  187  186  185  184  Older
DateSubjectAuthorDiscuss
12/6/2019
22:35
AMYT for me was always a punt on the outcome of the phase III trial for AP101. Existing AMYT shareholders have been promised US$85m if AP101 comes up trumps. That sum is independent of the share price of the relisted AMYT. PS I don't believe mdalos's analysis and figures are correct. AMYT have stated (RNS dated 21/5/2019) that the US$60m placing price will be at a 20% discount to the ESTIMATED value of AMYT prior to the completion of the acquisition of Aegerion. That estimated value is US$120m according to that RNS. Hence, unless AMYT are telling porkies, the consolidation will not affect the increase in value of our AMYT shares on relisting. As usual mdalos twists the facts to suit his agenda. Basically he's a compulsive liar who deletes his posts. Only time will tell if AMYT are also being economical with the truth with regard to their RNS dated 21/5/2019. I'm hoping that the action of the AMYT share price on relisting will be similar to what has happened at VENN. The placing price was significantly higher than the suspension price. This led to a big jump up in the VENN share price when it relisted yesterday. The VENN share price was suspended around 2.6p, but the recent placing was priced at 5.6p and the share price closed today at 5.3p. That's around double the suspension price. How they managed to get a placing away at 5.6p baffles me (and probably baffles mdalos!), but they did (there was no share consolidation with VENN). I'm hopeful that similar happens with AMYT and that my £2.8k becomes worth over £5k when AMYT relists. PPS. AMYT had to consolidate to get the share price higher because of the proposed Nasdaq listing. This consolidation should ensure the placing is priced north of a dollar.
papillon
12/6/2019
20:18
Interesting it seems Marc Summeray Amryt's CMO is being sued for fraud by the state of Massachusetts?
chica1
12/6/2019
20:10
Exactly Waterloo.
bermudashorts
12/6/2019
18:49
Actually you also need to add in the shares and the assets/market cap into the equation of the take over. Te market cap of the two combined will be a lot higher, as will the shares issued to make the acquisition. Lots still unknown
waterloo01
12/6/2019
18:15
mdalos1, That's just wrong. As you like examples, this is what I believe will occur Before consolidation: Amryt has 276m shares in circulation, share price is 12.5p = market Cap = £34.5 After 6:1 consolidation: Amryt has 276/6 = 46m shares in circulation, market cap remains at £34.5 as assets still the same, thus new consolidated share price = £34.5m / 46m = 75p Whatever happens to Amryt after the deal concludes will be referenced from a starting position of 75p
dlm2602
12/6/2019
13:58
I'm assuming the US$85m promised to existing AMYT shareholders (in cash, or shares) if AP101 is a "rip roaring" success will be to AMYT shareholders on the register at the 21/5/2019 suspension. It doesn't make sense otherwise since once the new company relists it will include new shareholders.
papillon
12/6/2019
13:49
So for every 6 shares held pre suspension we will end up with ONE share (excluding fractions). That means the relisted share price will need to be 74.250p to equal the suspension price of 12.375p. The share price for the US$60m placing was forecast to be 27.5p based on estimated value for AMYT of US$120m post acquisition (RNS 21/5/2019). That means they intend to place shares at 165p to account for the 1 for 6 consolidation. I'LL BELIEVE IT WHEN I SEE IT!!!! I'm DEFINITELY NOT counting my chickens until they have hatched!!!! Meanwhile there is nothing I can do about it until the shares relist (hopefully!) in October.
papillon
12/6/2019
13:14
Seeing he'll soon delete it I've taken the liberty of copying and pasting mdalos's post. Make of it what you will mdalos1 - 12 Jun 2019 - 09:14:29 - 4549 of 4551 Amryt Pharma - AMYT https://www.londonstockexchange.com/exchange/news/market-news/market-news-detail/AMYT/14107291.html Share consolidation, reduction in shares in issue BUT company funds being used to take them out of circulation, ultimately we'll need to try to associate the approx. 16% of shares in issue left in circulation with the dubious numbers already being touted by the takeover/acquisition/merger/reverse takeover activities to fathom where we might stand when the Business returns to Market !!!! 50% chance we're going to lose out 50% chance of a one-time, brief opportunity to benefit
papillon
12/6/2019
10:27
mdalos1 I don't share your pessimism here. This is standard practice and will not affect the cash in the business at all other than the administrative expense in doing the exercise. The $ value attributed to Amryt in the deal with Aegerion remains the same.
dlm2602
11/6/2019
14:34
Bronxville Posts: 1,117 Opinion: No Opinion Price: 12.375 Open Orphan Today 13:46 I figured my punt would payoff.. Nice little earner in at 1.74 out at 5.30..Will keep some for interest.. Venn Life have some decent revenues(15 mil) Cathal Friel will cut the fat I guess They also own 42 million shares of Integumen (SKIN) worth €1million.. >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> Congratulations are in order, Bronxville. Well done on your very successful punt on VENN. I believe you have done the right thing by selling most of your shares today. I hope my £2.8k punt on AMYT (23k+ shares) is as equally successful when AMYT eventually relists, hopefully sometime in October.
papillon
11/6/2019
12:54
Yes, alphabravo, VENN is up around 90% on relisting. It's today's biggest riser after getting a placing away at 5.6p. The share price is currently 5p. Is it defying gravity, I wonder? I think that might be the case. After all AMYT shares were placed at 24p back in early summer 2016p, but around 6 months later it had drifted down to around 14p before the good news released in December 2016 pushed the share price back up towards the placing price. Open Orphan has effectively RTO'd into VENN. VENN have issued just over 100m shares priced at 5.6p to purchase Open Orphan. I can't see that Open Orphan is anything more than a shell with no apparent tangible assets apart from Cathal Friel!
papillon
11/6/2019
08:28
Nice stroke from Cathal F over at Venn...
alphabravo321
09/6/2019
13:25
I missed that post, MADLOSS, as you'd already deleted it! What's the point of posting if you delete it before anyone has a chance of reading it? It's like secret agents writing messages in invisible ink to evade detection, Strange behaviour. LOLs
papillon
07/6/2019
21:04
mdalos1 - 07 Jun 2019 - 18:57:31 - 4542 of 4543 Amryt Pharma - AMYT WHAT A TW@T... LOLs >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> Being called a "TW@T" by a T@SSER who deletes his posts I take as a compliment! LOLs
papillon
07/6/2019
11:46
Of course the BIG difference between this AMYT takeover of Aegerion (RTO) and the Amicus takeover of Socioderm is that AMYT are NOT on the receiving end of a takeover bid, unlike Socioderm. Aegerion are being taken over. It's a big shame that AMYT haven't been on the end of a takeover bid. That was what Cathal Friel was predicting back in May 2016 would happen to AMYT in two years time (summer 2018). It was what I was hoping for as well. Was no one that interested in AP101 to make them bid for AMYT? It does look like that. PS I'll be very, very, disappointed (gutted in fact!) if the promised US$60m placing, promised at a 20% discount to the estimated value of AMYT, doesn't happen in accordance with the 21st May RNS. That would mean a placing price of 27.5p. 27.5p would be around double what I paid for my shares.
papillon
Chat Pages: Latest  195  194  193  192  191  190  189  188  187  186  185  184  Older
ADVFN Advertorial
Your Recent History
LSE
AMYT
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210619 14:32:01